Daljit Singh Aurora
See Remarks at Neumora Therapeutics, Inc. (NMRA)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 21SEC | NMRANeumora Therapeutics, Inc. | Sell | 67,74148,750 held (−58%) | $1.51 | $102K | -68.5% |
| Aug 21SEC | NMRANeumora Therapeutics, Inc. | Sell | 66,711 | $1.51 | $101K | -68.5% |
| Aug 21SEC | NMRANeumora Therapeutics, Inc. | Sell | 20,55348,750 held (−30%) | $1.59 | $33K | -70.1% |
| Aug 21SEC | NMRANeumora Therapeutics, Inc. | Sell | 21,055 | $1.60 | $34K | -70.2% |
| Aug 19SEC | NMRANeumora Therapeutics, Inc. | Sell | 57,67082,770 held (−41%) | $1.51 | $87K | -68.5% |
| Aug 19SEC | NMRANeumora Therapeutics, Inc. | Sell | 34,02048,750 held (−41%) | $1.49 | $51K | -68.1% |
| Aug 19SEC | NMRANeumora Therapeutics, Inc. | Sell | 55,016 | $1.50 | $83K | -68.3% |
| Aug 19SEC | NMRANeumora Therapeutics, Inc. | Sell | 34,16248,750 held (−41%) | $1.58 | $54K | -69.9% |
| Aug 19SEC | NMRANeumora Therapeutics, Inc. | Sell | 34,987 | $1.59 | $56K | -70.1% |
| Aug 19SEC | NMRANeumora Therapeutics, Inc. | Sell | 31,00048,750 held (−39%) | $1.65 | $51K | -71.2% |
| Aug 19SEC | NMRANeumora Therapeutics, Inc. | Sell | 30,918 | $1.65 | $51K | -71.2% |
| Feb 19SEC | NMRANeumora Therapeutics, Inc. | Sell | 6,16582,770 held (−7%) | $3.56 | $22K | -86.6% |
| Nov 13SEC | NMRANeumora Therapeutics, Inc. | Sell Plan | 114,703 | $2.68 | $307K | -82.2% |
- Sell
See Remarks Daljit Singh Aurora sold $102K of NMRA at $1.51 — cuts the stake by 58%.
- Sell
See Remarks Daljit Singh Aurora sold $33K of NMRA at $1.59 — cuts the stake by 30%.
- Sell
See Remarks Daljit Singh Aurora sold $87K of NMRA at $1.51 — cuts the stake by 41%.
- Sell
See Remarks Daljit Singh Aurora sold $51K of NMRA at $1.49 — cuts the stake by 41%.
- Sell
See Remarks Daljit Singh Aurora sold $54K of NMRA at $1.58 — cuts the stake by 41%.
- Sell
See Remarks Daljit Singh Aurora sold $51K of NMRA at $1.65 — cuts the stake by 39%.